Candriam SCA’s Genpact G Stock Holding History

Candriam SCA’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,897	Closed	-$656K	–	677
2025 Q2	$656K	Buy	+14,897	New	+$675K	﹤0.01%	625
2024 Q4	–	Sell	-72,387	Closed	-$2.84M	–	685
2024 Q3	$2.84M	Buy	+72,387	New	+$2.62M	0.02%	448

Other funds holding G

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NIEF

Nalanda India Equity Fund Mauritius $377M AUM 37.51% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Candriam SCA's G Position: Q3 2025 in Review

Candriam SCA sold out of Genpact (G) in Q3 2025, closing a stake of 14,897 shares — an estimated $656K sold.

Candriam SCA first reported a position in G in Q3 2024 and held it in 2 quarters. The position peaked at $2.84M in Q3 2024. 493 funds tracked by Wall St. Rank hold G as of Q3 2025.

Candriam SCA reported no remaining Genpact position as of Q3 2025 after selling out during the quarter.
Candriam SCA sold 14,897 Genpact shares in Q3 2025, an estimated $656K.
Candriam SCA first reported a position in Genpact in Q3 2024 and held it in 2 quarters.
Candriam SCA's Genpact position peaked at $2.84M in Q3 2024.
493 funds tracked by Wall St. Rank held Genpact as of Q3 2025.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.